-
1دورية أكاديمية
المؤلفون: Raquel Aguiar-Ibáñez, Emilie Scherrer, Dmitri Grebennik, John Cook, Shalini Bagga, Baanie Sawhney, Anvi Khandelwal, Scott A. Soefje
المصدر: BMC Health Services Research, Vol 23, Iss 1, Pp 1-10 (2023)
مصطلحات موضوعية: Immunotherapies, Pembrolizumab, Nivolumab, Survey, Productivity loss, Infusion visit, Public aspects of medicine, RA1-1270
وصف الملف: electronic resource
العلاقة: https://doaj.org/toc/1472-6963Test
-
2دورية أكاديمية
المؤلفون: Peter Mohr, Emilie Scherrer, Chalid Assaf, Marc Bender, Carola Berking, Sheenu Chandwani, Thomas Eigentler, Imke Grimmelmann, Ralf Gutzmer, Sebastian Haferkamp, Jessica C. Hassel, Axel Hauschild, Rudolf Herbst, Ruixuan Jiang, Katharina C. Kähler, Clemens Krepler, Alexander Kreuter, Ulrike Leiter, Carmen Loquai, Friedegund Meier, Claudia Pföhler, Anja Rudolph, Dirk Schadendorf, Maximo Schiavone, Gaston Schley, Patrick Terheyden, Selma Ugurel, Jens Ulrich, Jochen Utikal, Carsten Weishaupt, Julia Welzel, Michael Weichenthal
المصدر: Cancers, Vol 14, Iss 7, p 1804 (2022)
مصطلحات موضوعية: advanced melanoma, surrogate endpoint, real-world evidence, overall survival (OS), time to next treatment (rwTtNT), pembrolizumab, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
3
المؤلفون: Gaëlle Farge, Laurent Mortier, Stéphane Dalle, Olivier Dereure, Sheenu Chandwani, Caroline Dutriaux, Sophie Dalac, Laurie Levy-Bachelot, Laetitia Verdoni, Emilie Scherrer, Clara Allayous, Céleste Lebbé, Emilie Casarotto, B. Oriano
المساهمون: MSD France, Merck & Co. Inc, CHU Lille, Thérapies Laser Assistées par l'Image pour l'Oncologie - U 1189 (ONCO-THAI), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), CHU Montpellier, Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Hôpital Saint-André, CHU Dijon, Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Hopital Saint-Louis [AP-HP] (AP-HP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Hospices Civils de Lyon (HCL), Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL), Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Immunologie humaine, physiopathologie & immunothérapie (HIPI (UMR_S_976 / U976)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité)
المصدر: Immunotherapy
Immunotherapy, 2021, 13 (11), pp.905-916. ⟨10.2217/imt-2021-0077⟩مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Skin Neoplasms, Databases, Factual, [SDV]Life Sciences [q-bio], medicine.medical_treatment, Immunology, Kaplan-Meier Estimate, Pembrolizumab, Antibodies, Monoclonal, Humanized, computer.software_genre, Tumor response, survival, Cohort Studies, 03 medical and health sciences, 0302 clinical medicine, cohort study, medicine, Overall survival, Humans, Immunology and Allergy, Stage (cooking), Immune Checkpoint Inhibitors, Melanoma, Aged, Advanced melanoma, Aged, 80 and over, Database, business.industry, Immunotherapy, Middle Aged, medicine.disease, Treatment Outcome, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Female, immunotherapy, pembrolizumab, France, business, computer, Cohort study
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2eeecf15ac2f76c4e915b9fc7920c053Test
https://doi.org/10.2217/imt-2021-0077Test -
4
المؤلفون: Victoria Wurcel, Juan Ignacio Altuna, Fernando Carabajal, Gargi Baluni, Raquel Aguiar-Ibáñez, Shrishti Jain, Emilie Scherrer
المصدر: Oncology and Therapy
مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Cost effectiveness, Melanoma, medicine.medical_treatment, Hazard ratio, Argentina, Pembrolizumab, Adjuvant treatment, medicine.disease, Confidence interval, Latin America, Internal medicine, Medicine, Cost-effectiveness, Stage (cooking), business, health care economics and organizations, Reimbursement, Watchful waiting, Original Research
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37ffa07f0b556a00966d5479d4441a82Test
https://doi.org/10.1007/s40487-021-00142-8Test -
5
المؤلفون: Xiaoyun Li, Cathy Anne Pinto, Emilie Scherrer, Mizuho Kalabis, Xinyue Liu
المصدر: Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
مصطلحات موضوعية: medicine.medical_specialty, Chemotherapy, Combination therapy, business.industry, medicine.medical_treatment, Medical record, Disease progression, Pembrolizumab, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, lcsh:RC254-282, Stable Disease, Internal medicine, medicine, Nivolumab, business, Social Security Death Index
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67a08aa4a18c0690b927dab1976b7af3Test
https://doaj.org/article/1bfc61267f7a45059e87b4fee703575bTest -
6صورة
المؤلفون: Adis journals on behalf of (9646728), Victoria Wurcel (10010603), Emilie Scherrer (7045235), Raquel Aguiar-Ibanez (10010605), Juan Ignacio Altuna (10010607), Fernando Carabajal (10010608), Shrishti Jain (10010609), Gargi Baluni (10010612)
مصطلحات موضوعية: Medicine, Cancer, Dermatology, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Oncology and Carcinogenesis not elsewhere classified, Health Economics, Adjuvant treatment, Argentina, Cost-effectiveness, Latin America, Melanoma, Pembrolizumab
-
7
المؤلفون: Anvi Khandelwal, Baanie Sawhney, John Cook, Emilie Scherrer, Shalini Bagga, Raquel Aguiar-Ibáñez, Dmitri Grebennik, Scott Soefje
المصدر: Journal for ImmunoTherapy of Cancer. 9:A941-A941
مصطلحات موضوعية: Pharmacology, Oncology, Cancer Research, medicine.medical_specialty, Schedule, business.industry, Melanoma, medicine.medical_treatment, Immunology, Pembrolizumab, medicine.disease, Internal medicine, Molecular Medicine, Immunology and Allergy, Medicine, Dosing, business, Adjuvant
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::7af1f3e3202f213bbd013952090a7809Test
https://doi.org/10.1136/jitc-2021-sitc2021.897Test -
8
المؤلفون: Arielle G. Bensimon, Wei Gao, Madeline Jenkins, Emilie Scherrer, James Signorovitch, Raquel Aguiar-Ibáñez, Zheng-Yi Zhou, Clemens Krepler, Jingshu Wang, Yan Song
المصدر: Clinical Drug Investigation
مصطلحات موضوعية: Oncology, Male, medicine.medical_specialty, medicine.medical_treatment, Cost-Benefit Analysis, Population, Ipilimumab, Pembrolizumab, 030204 cardiovascular system & hematology, Placebo, Antibodies, Monoclonal, Humanized, 030226 pharmacology & pharmacy, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Humans, Pharmacology (medical), Original Research Article, Adverse effect, education, Melanoma, Neoplasm Staging, Trametinib, education.field_of_study, business.industry, Dabrafenib, General Medicine, Health Care Costs, Middle Aged, Female, Quality-Adjusted Life Years, business, Adjuvant, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc665ba8e733bfe3fa1a444a1858bd33Test
https://pubmed.ncbi.nlm.nih.gov/32418051Test -
9
المؤلفون: Todd A. Lee, Frank Xiaoqing Liu, Alicia C. Shillington, Emilie Scherrer, Vaidehi Dave, Scott J. Diede, Richard W. Joseph, Qing Harshaw, Cynthia Macahilig
المصدر: Journal of medical economics. 23(2)
مصطلحات موضوعية: Oncology, Male, Skin Neoplasms, medicine.medical_treatment, Pembrolizumab, Comorbidity, Severity of Illness Index, 0302 clinical medicine, Antineoplastic Agents, Immunological, hemic and lymphatic diseases, Antineoplastic Combined Chemotherapy Protocols, Neoplasm Metastasis, Melanoma, Aged, 80 and over, 030503 health policy & services, Health Policy, Age Factors, Health Services, Middle Aged, Hospitalization, Nivolumab, 030220 oncology & carcinogenesis, Health Resources, Female, 0305 other medical science, Emergency Service, Hospital, medicine.drug, Adult, medicine.medical_specialty, Ipilimumab, Antibodies, Monoclonal, Humanized, Disease-Free Survival, 03 medical and health sciences, Sex Factors, Internal medicine, medicine, Humans, Advanced melanoma, Aged, Neoplasm Staging, Retrospective Studies, business.industry, Immunotherapy, Emergency department, medicine.disease, Regimen, Socioeconomic Factors, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea03f3e3d324c5e59f46dbc80ab03ca2Test
https://pubmed.ncbi.nlm.nih.gov/31750751Test -
10
المؤلفون: Emilie Scherrer, Frank Xiaoqing Liu, Raquel Aguiar-Ibáñez, Maria Lorenzi, Stella Arndorfer, Clemens Krepler
المصدر: Journal of Drug Assessment
مصطلحات موضوعية: Oncology, medicine.medical_specialty, medicine.medical_treatment, Pembrolizumab, 030204 cardiovascular system & hematology, 03 medical and health sciences, 0302 clinical medicine, Indirect Treatment, Internal medicine, melanoma, medicine, Adjuvant therapy, Stage III melanoma, business.industry, indirect treatment comparison, Melanoma, adjuvant therapy, Immunotherapy, medicine.disease, PD-1 inhibitor, Systematic review, immunotherapy, business, Adjuvant, 030217 neurology & neurosurgery
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8f0bc61b33102d0182d0e731ab33821Test